Does the media refer more to SRTS or STIM?

In the previous week, Sensus Healthcare and Sensus Healthcare both had 2 articles in the media. Sensus Healthcare's average media sentiment score of 0.51 beat Neuronetics' score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sensus Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Neuronetics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer SRTS or ZJYL?

Sensus Healthcare currently has a consensus target price of $5.83, indicating a potential upside of 92.52%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Sensus Healthcare is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, SRTS or ZJYL?

Jin Medical International has higher revenue and earnings than Sensus Healthcare. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sensus Healthcare $17.51M 2.85 -$7.72M -$0.94 N/A Jin Medical International $20.69M 7.77 $1.19M N/A N/A

Does the media prefer KRMD or SRTS?

In the previous week, KORU Medical Systems and KORU Medical Systems both had 2 articles in the media. KORU Medical Systems' average media sentiment score of 0.67 beat Sensus Healthcare's score of 0.51 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sensus Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer INGN or SRTS?

Sensus Healthcare has a consensus target price of $5.83, indicating a potential upside of 92.52%. Given Sensus Healthcare's higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Sensus Healthcare 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50

Does the media prefer INGN or SRTS?

In the previous week, Inogen and Inogen both had 2 articles in the media. Sensus Healthcare's average media sentiment score of 0.51 beat Inogen's score of 0.05 indicating that Sensus Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inogen 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sensus Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Sensus Healthcare (SRTS) Competitors

$3.03 -0.07 (-2.26%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$3.03 0.00 (0.00%)

As of 09/23/2026 07:30 PM Eastern

Compare

SRTS vs. STIM, FOCL, ZJYL, KRMD, and INGN

Should you buy Sensus Healthcare stock or one of its competitors? Sensus Healthcare's main competitors and comparable companies include Neuronetics (STIM), FocalTherics (FOCL), Jin Medical International (ZJYL), KORU Medical Systems (KRMD), and Inogen (INGN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sensus Healthcare compare to Neuronetics?

Sensus Healthcare (NASDAQ:SRTS) and Neuronetics (NASDAQ:STIM) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

In the previous week, Sensus Healthcare and Sensus Healthcare both had 2 articles in the media. Sensus Healthcare's average media sentiment score of 0.51 beat Neuronetics' score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sensus Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Neuronetics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 53.6% of Neuronetics shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by company insiders. Comparatively, 8.4% of Neuronetics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Neuronetics has a net margin of -19.62% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-21.57%	-19.20%
Neuronetics	-19.62%	-125.11%	-22.15%

Sensus Healthcare has higher earnings, but lower revenue than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$17.51M	2.85	-$7.72M	-$0.94	N/A
Neuronetics	$149.16M	1.47	-$39M	-$0.44	N/A

Sensus Healthcare currently has a consensus price target of $5.83, suggesting a potential upside of 92.52%. Neuronetics has a consensus price target of $4.67, suggesting a potential upside of 62.04%. Given Sensus Healthcare's higher possible upside, equities research analysts plainly believe Sensus Healthcare is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Sensus Healthcare has a beta of 1.13, meaning that its stock price is 13% more volatile than the broader market. Comparatively, Neuronetics has a beta of 1.16, meaning that its stock price is 16% more volatile than the broader market.

Summary

Sensus Healthcare beats Neuronetics on 8 of the 14 factors compared between the two stocks.

How does Sensus Healthcare compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, media sentiment, valuation, analyst recommendations and profitability.

62.7% of FocalTherics shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 10.1% of FocalTherics shares are held by insiders. Comparatively, 10.2% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

FocalTherics has a beta of -0.07, suggesting that its stock price is 107% less volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.13, suggesting that its stock price is 13% more volatile than the broader market.

In the previous week, Sensus Healthcare had 2 more articles in the media than FocalTherics. MarketBeat recorded 2 mentions for Sensus Healthcare and 0 mentions for FocalTherics. Sensus Healthcare's average media sentiment score of 0.51 beat FocalTherics' score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
FocalTherics	Neutral
Sensus Healthcare	Positive

FocalTherics currently has a consensus target price of $7.75, indicating a potential upside of 63.50%. Sensus Healthcare has a consensus target price of $5.83, indicating a potential upside of 92.52%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Sensus Healthcare is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Sensus Healthcare has lower revenue, but higher earnings than FocalTherics. FocalTherics is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FocalTherics	$70.53M	2.52	-$29.25M	-$1.03	N/A
Sensus Healthcare	$17.51M	2.85	-$7.72M	-$0.94	N/A

FocalTherics has a net margin of -56.26% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FocalTherics	-56.26%	-248.00%	-44.69%
Sensus Healthcare	-88.45%	-21.57%	-19.20%

Summary

Sensus Healthcare beats FocalTherics on 13 of the 17 factors compared between the two stocks.

How does Sensus Healthcare compare to Jin Medical International?

Sensus Healthcare (NASDAQ:SRTS) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends.

Jin Medical International has higher revenue and earnings than Sensus Healthcare.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$17.51M	2.85	-$7.72M	-$0.94	N/A
Jin Medical International	$20.69M	7.77	$1.19M	N/A	N/A

Sensus Healthcare currently has a consensus target price of $5.83, indicating a potential upside of 92.52%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Sensus Healthcare is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Sensus Healthcare has a beta of 1.13, suggesting that its share price is 13% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.31, suggesting that its share price is 631% more volatile than the broader market.

In the previous week, Sensus Healthcare had 2 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for Sensus Healthcare and 0 mentions for Jin Medical International. Sensus Healthcare's average media sentiment score of 0.51 beat Jin Medical International's score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media.

Company	Overall Sentiment
Sensus Healthcare	Positive
Jin Medical International	Neutral

25.3% of Sensus Healthcare shares are owned by institutional investors. 10.2% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Jin Medical International has a net margin of 0.00% compared to Sensus Healthcare's net margin of -88.45%. Jin Medical International's return on equity of 0.00% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-21.57%	-19.20%
Jin Medical International	N/A	N/A	N/A

Summary

Sensus Healthcare and Jin Medical International tied by winning 7 of the 14 factors compared between the two stocks.

How does Sensus Healthcare compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

In the previous week, KORU Medical Systems and KORU Medical Systems both had 2 articles in the media. KORU Medical Systems' average media sentiment score of 0.67 beat Sensus Healthcare's score of 0.51 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sensus Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

KORU Medical Systems has a net margin of -4.03% compared to Sensus Healthcare's net margin of -88.45%. KORU Medical Systems' return on equity of -10.63% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Sensus Healthcare	-88.45%	-21.57%	-19.20%

KORU Medical Systems currently has a consensus target price of $7.00, indicating a potential upside of 114.07%. Sensus Healthcare has a consensus target price of $5.83, indicating a potential upside of 92.52%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, research analysts plainly believe KORU Medical Systems is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.13, suggesting that its stock price is 13% more volatile than the broader market.

KORU Medical Systems has higher revenue and earnings than Sensus Healthcare. KORU Medical Systems is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$45.11M	3.33	-$2.64M	-$0.04	N/A
Sensus Healthcare	$17.51M	2.85	-$7.72M	-$0.94	N/A

Summary

KORU Medical Systems beats Sensus Healthcare on 12 of the 14 factors compared between the two stocks.

How does Sensus Healthcare compare to Inogen?

Inogen (NASDAQ:INGN) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.

Sensus Healthcare has a consensus target price of $5.83, indicating a potential upside of 92.52%. Given Sensus Healthcare's higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Inogen and Inogen both had 2 articles in the media. Sensus Healthcare's average media sentiment score of 0.51 beat Inogen's score of 0.05 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inogen	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sensus Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Inogen has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.13, indicating that its stock price is 13% more volatile than the broader market.

89.9% of Inogen shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 2.5% of Inogen shares are owned by company insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Inogen has a net margin of -6.94% compared to Sensus Healthcare's net margin of -88.45%. Inogen's return on equity of -13.17% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-6.94%	-13.17%	-8.36%
Sensus Healthcare	-88.45%	-21.57%	-19.20%

Sensus Healthcare has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$348.67M	0.39	-$22.75M	-$0.90	N/A
Sensus Healthcare	$17.51M	2.85	-$7.72M	-$0.94	N/A

Summary

Inogen beats Sensus Healthcare on 8 of the 15 factors compared between the two stocks.

Get Sensus Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SRTS vs. The Competition

Export

Metric	Sensus Healthcare	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$51.03M	$5.58B	$7.31B	$13.29B
Dividend Yield	N/A	1.79%	2.52%	12.57%
P/E Ratio	-3.22	25.26	274.08	25.69
Price / Sales	2.85	71.56	638.21	78.99
Price / Cash	N/A	33.02	77.80	52.76
Price / Book	1.03	5.78	10.47	6.32
Net Income	-$7.72M	$151.55M	$3.49B	$359.73M
7 Day Performance	-2.88%	-0.01%	-0.67%	0.17%
1 Month Performance	-13.18%	-3.53%	-3.17%	-3.27%
1 Year Performance	-4.11%	6.37%	15.14%	5.58%

Sensus Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SRTS Sensus Healthcare	3.0914 of 5 stars	$3.03 -2.3%	$5.83 +92.5%	-4.1%	$51.03M	$17.51M	N/A	60
STIM Neuronetics	3.4622 of 5 stars	$2.71 -6.4%	$4.67 +72.0%	+4.7%	$206.12M	$149.16M	N/A	658
FOCL FocalTherics	3.626 of 5 stars	$4.19 +1.9%	$7.75 +85.0%	N/A	$157.24M	$79.31M	N/A	230
ZJYL Jin Medical International	N/A	$1.99 +1.2%	N/A	-81.7%	$156.39M	$20.69M	N/A	245
KRMD KORU Medical Systems	3.778 of 5 stars	$3.17 +0.8%	$7.00 +121.2%	-18.9%	$145.37M	$41.13M	N/A	80	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SRTS) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sensus Healthcare (SRTS) Competitors

SRTS vs. STIM, FOCL, ZJYL, KRMD, and INGN

How does Sensus Healthcare compare to Neuronetics?

Summary

How does Sensus Healthcare compare to FocalTherics?

Summary

How does Sensus Healthcare compare to Jin Medical International?

Summary

How does Sensus Healthcare compare to KORU Medical Systems?

Summary

How does Sensus Healthcare compare to Inogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTS vs. The Competition

Sensus Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sensus Healthcare (SRTS) Competitors

SRTS vs. STIM, FOCL, ZJYL, KRMD, and INGN

How does Sensus Healthcare compare to Neuronetics?

Does the media refer more to SRTS or STIM?

Do institutionals and insiders hold more shares of SRTS or STIM?

Is SRTS or STIM more profitable?

Which has stronger valuation and earnings, SRTS or STIM?

Do analysts recommend SRTS or STIM?

Which has more volatility and risk, SRTS or STIM?

Summary

How does Sensus Healthcare compare to FocalTherics?

Do insiders & institutionals have more ownership in FOCL or SRTS?

Which has more volatility and risk, FOCL or SRTS?

Does the media prefer FOCL or SRTS?

Do analysts rate FOCL or SRTS?

Which has higher valuation & earnings, FOCL or SRTS?

Is FOCL or SRTS more profitable?

Summary

How does Sensus Healthcare compare to Jin Medical International?

Which has preferable valuation and earnings, SRTS or ZJYL?

Do analysts prefer SRTS or ZJYL?

Which has more volatility & risk, SRTS or ZJYL?

Does the media refer more to SRTS or ZJYL?

Do insiders & institutionals have more ownership in SRTS or ZJYL?

Is SRTS or ZJYL more profitable?

Summary

How does Sensus Healthcare compare to KORU Medical Systems?

Does the media prefer KRMD or SRTS?

Do insiders & institutionals believe in KRMD or SRTS?

Is KRMD or SRTS more profitable?

Do analysts recommend KRMD or SRTS?

Which has more risk and volatility, KRMD or SRTS?

Which has higher earnings and valuation, KRMD or SRTS?

Summary

How does Sensus Healthcare compare to Inogen?

Do analysts prefer INGN or SRTS?

Does the media prefer INGN or SRTS?

Which has more risk and volatility, INGN or SRTS?

Do institutionals and insiders have more ownership in INGN or SRTS?

Is INGN or SRTS more profitable?

Which has preferable earnings and valuation, INGN or SRTS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTS vs. The Competition

Sensus Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools